AI vs. human eye: study tests computer vision to spot diabetic blindness risk
NCT ID NCT07222293
Summary
This study is testing whether an artificial intelligence (AI) software called DRISTi can accurately screen for diabetic retinopathy, a serious eye complication of diabetes. It will enroll 900 adults with diabetes to have photos of their retinas taken. The AI's analysis of these photos will be compared to evaluations by human eye specialists to see if the software is a reliable diagnostic tool.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Century Ophthalmology - Oxford
RECRUITINGOxford, North Carolina, 27565, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
New Century Ophthalmology - Raleigh
RECRUITINGRaleigh, North Carolina, 27617, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.